Dana Hilt

Dana Hilt

Directeur Technique/Scientifique/R&D chez ACTINOGEN MEDICAL LIMITED
73 ans
Health Technology
Consumer Services

Profil

Dana Charles Hilt is currently Chief Medical Officer at Actinogen Medical Ltd. since 2023.
Former positions include Director-Clinical Neurosciences at Amgen, Inc., Vice President-Clinical Research at Guilford Pharmaceuticals, Inc., Chief Medical Officer at Critical Therapeutics, Inc. from 2006 to 2007, Chief Medical Officer & SVP-Drug Development at FORUM Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Research at Ascend Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Research at ASCEND Therapeutics US LLC, Chief Medical Officer at Lysosomal Therapeutics, Inc. from 2016 to 2019, Chief Medical Officer at Frequency Therapeutics, Inc., and Chief Medical Officer at Brenig Therapeutics, Inc. Education includes undergraduate studies at the University of Maine and a doctorate from Tufts University School of Medicine.

Postes actifs de Dana Hilt

SociétésPosteDébut
ACTINOGEN MEDICAL LIMITED Directeur Technique/Scientifique/R&D 01/02/2023

Anciens postes connus de Dana Hilt

SociétésPosteFin
Directeur Technique/Scientifique/R&D 10/06/2025
Directeur Technique/Scientifique/R&D 01/08/2019
Directeur Technique/Scientifique/R&D 25/09/2007
Directeur Technique/Scientifique/R&D -
KORRO BIO, INC. Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Dana Hilt

Formation de Dana Hilt

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

11

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Ascend Pharmaceuticals, Inc.

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT